• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎中环状RNA的表达谱及N6-甲基腺嘌呤修饰分析

Expression profile and N6-methyadenosine modification of circular RNA analysis in MAFLD.

作者信息

Zheng Mengyao, Cun Dongyun, He Haiyu, Xie Xuancheng, Lei Hongtao, Fu Wen, Tai Wenlin, Yang Jinhui

机构信息

Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, China.

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650101, China.

出版信息

BMC Gastroenterol. 2025 Mar 11;25(1):162. doi: 10.1186/s12876-025-03722-4.

DOI:10.1186/s12876-025-03722-4
PMID:40069595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11899672/
Abstract

BACKGROUND

To analyze the expression patterns of circRNAs in metabolic associated fatty liver disease (MAFLD) and the regulation of mA methylation on those circRNAs.

METHODS

The expression profile of CircRNA in MAFLD and normal control liver tissues was analyzed by microarray. Predict the potential mA sites of the differentially expression circRNAs (DECs) via the SRAMP website. The biological functions and molecular interactions of DECs were analyzed by GO and KEGG analyses. The selected DECs were verified by MeRIP-qPCR and RT-qPCR.

RESULTS

There were 59 DECs in MAFLD liver tissues compared with normal control liver tissues. We found that mA sites with high or very high confidence were present in 39 of these DECs. Four randomly selected DECs were validated by RT-qPCR, hsa-MLIP_0004, hsa-CHD2_0084 and hsa-FOXP1_0001 matched well with the microarray results. mA qualification of them were conducted by MeRIP-qPCR, the mA methylation levels are significantly different between the MAFLD and NC groups.

CONCLUSION

In MAFLD, the dysregulated expression of circRNAs may be influenced by mA modifications. This study provides preliminary evidence suggesting that mA-mediated regulation of circRNAs could play a role in the progression of MAFLD, laying the foundation for exploring the epigenetic regulation of circRNAs in MAFLD and offering potential avenues for future diagnostic and therapeutic strategies.

TRIAL REGISTRATION

Not applicable.

摘要

背景

分析环状RNA(circRNAs)在代谢相关脂肪性肝病(MAFLD)中的表达模式以及m⁶A甲基化对这些circRNAs的调控作用。

方法

通过微阵列分析MAFLD和正常对照肝脏组织中circRNA的表达谱。通过SRAMP网站预测差异表达circRNAs(DECs)的潜在m⁶A位点。通过基因本体(GO)和京都基因与基因组百科全书(KEGG)分析来分析DECs的生物学功能和分子相互作用。通过甲基化RNA免疫沉淀定量PCR(MeRIP-qPCR)和逆转录定量PCR(RT-qPCR)对所选的DECs进行验证。

结果

与正常对照肝脏组织相比,MAFLD肝脏组织中有59个DECs。我们发现其中39个DECs存在高置信度或非常高置信度的m⁶A位点。通过RT-qPCR对随机选择的4个DECs进行验证,hsa-MLIP_0004、hsa-CHD2_0084和hsa-FOXP1_0001与微阵列结果匹配良好。通过MeRIP-qPCR对它们进行m⁶A鉴定,MAFLD组和正常对照组之间的m⁶A甲基化水平存在显著差异。

结论

在MAFLD中,circRNAs的表达失调可能受m⁶A修饰影响。本研究提供了初步证据,表明m⁶A介导的circRNAs调控可能在MAFLD的进展中起作用,为探索MAFLD中circRNAs的表观遗传调控奠定了基础,并为未来的诊断和治疗策略提供了潜在途径。

试验注册

不适用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/0f63029ecdc8/12876_2025_3722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/707ce473bf04/12876_2025_3722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/a5dc0f44cdec/12876_2025_3722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/17a4007ac718/12876_2025_3722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/0f63029ecdc8/12876_2025_3722_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/707ce473bf04/12876_2025_3722_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/a5dc0f44cdec/12876_2025_3722_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/17a4007ac718/12876_2025_3722_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/11899672/0f63029ecdc8/12876_2025_3722_Fig4_HTML.jpg

相似文献

1
Expression profile and N6-methyadenosine modification of circular RNA analysis in MAFLD.非酒精性脂肪性肝炎中环状RNA的表达谱及N6-甲基腺嘌呤修饰分析
BMC Gastroenterol. 2025 Mar 11;25(1):162. doi: 10.1186/s12876-025-03722-4.
2
Identification and characterization of circular RNAs expression profiles in obstructive sleep apnea-induced liver injury.阻塞性睡眠呼吸暂停诱导肝损伤中环状RNA表达谱的鉴定与特征分析
Aging (Albany NY). 2024 Mar 21;16(7):6262-6272. doi: 10.18632/aging.205701.
3
Circular RNA expression profile and m6A modification analysis in poorly differentiated adenocarcinoma of the stomach.环状 RNA 表达谱和 m6A 修饰分析在低分化胃腺癌中的作用。
Epigenomics. 2020 Jun;12(12):1027-1040. doi: 10.2217/epi-2019-0153. Epub 2020 Jul 13.
4
Differential expression and functional analysis of circular RNAs and m6A modifications in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病患儿中环状RNA和m6A修饰的差异表达及功能分析
Sci Rep. 2025 Apr 24;15(1):13976. doi: 10.1038/s41598-025-97345-0.
5
Genome-wide analysis of m6A-modified circRNAs in the mouse model of myocardial injury induced by obstructive sleep apnea.阻塞性睡眠呼吸暂停诱导的心肌损伤小鼠模型中m6A修饰的环状RNA的全基因组分析
BMC Pulm Med. 2025 Apr 5;25(1):158. doi: 10.1186/s12890-025-03609-w.
6
N6-methyladenosine methylation analysis of circRNAs in acquired middle ear cholesteatoma.获得性中耳胆脂瘤中环状RNA的N6-甲基腺苷甲基化分析
Front Genet. 2024 Jun 24;15:1396720. doi: 10.3389/fgene.2024.1396720. eCollection 2024.
7
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.参与MAFLD发生发展的环状RNA、非编码RNA和N6-甲基腺苷
Noncoding RNA. 2024 Feb 5;10(1):11. doi: 10.3390/ncrna10010011.
8
mA modifications of circular RNAs in ischemia-induced retinal neovascularization.环状 RNA 在缺血性诱导的视网膜新生血管化中的 mA 修饰。
Int J Med Sci. 2023 Jan 22;20(2):254-261. doi: 10.7150/ijms.79409. eCollection 2023.
9
Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.冠心病合并氯吡格雷抵抗患者的转录组范围内 N6-甲基腺苷(m6A)谱图分析
Clin Epigenetics. 2023 Dec 15;15(1):194. doi: 10.1186/s13148-023-01602-w.
10
METTL3-mediated m6A Modification of hsa_circ_0131922 Attenuates the Progression of Papillary Thyroid Cancer by Regulating the p53 Pathway.METTL3介导的hsa_circ_0131922的m6A修饰通过调控p53通路减弱甲状腺乳头状癌的进展。
Endocr Metab Immune Disord Drug Targets. 2025;25(6):492-502. doi: 10.2174/0118715303290063240530053252.

引用本文的文献

1
m6A modification of non‑coding RNA: Mechanisms, functions and potential values in human diseases (Review).非编码RNA的m6A修饰:机制、功能及在人类疾病中的潜在价值(综述)
Int J Mol Med. 2025 Oct;56(4). doi: 10.3892/ijmm.2025.5605. Epub 2025 Aug 8.

本文引用的文献

1
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma.环状 RNA RARS 与 IGF2BP3 协同作用,调节 RNA 甲基化识别,促进肾细胞癌的肿瘤进展。
Clin Transl Med. 2023 Dec;13(12):e1512. doi: 10.1002/ctm2.1512.
2
[High expression of Circ-PALLD in heart failure is transcriptionally regulated by the transcription factor GATA4].[Circ-PALLD在心力衰竭中的高表达受转录因子GATA4的转录调控]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Aug 20;43(8):1371-1378. doi: 10.12122/j.issn.1673-4254.2023.08.14.
3
CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling.
环状RNA hsa_circ_0008234通过调控miR-338-3p/ETS1轴和PI3K/AKT/mTOR信号通路促进结肠癌进展。
Cancers (Basel). 2023 Mar 30;15(7):2068. doi: 10.3390/cancers15072068.
4
YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.YTHDC1通过促进m6A修饰的circMPP1降解来维持滋养层细胞功能。
Biochem Pharmacol. 2023 Apr;210:115456. doi: 10.1016/j.bcp.2023.115456. Epub 2023 Feb 11.
5
Gene therapy targeting miR‑212‑3p exerts therapeutic effects on MAFLD similar to those of exercise.靶向 miR-212-3p 的基因治疗对 MAFLD 的治疗效果类似于运动。
Int J Mol Med. 2023 Feb;51(2). doi: 10.3892/ijmm.2023.5219. Epub 2023 Jan 12.
6
Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD.MAFLD 患者肝组织 miR-122-3p、miR-140-5p 和 miR-148b-5p 的表达与细胞角蛋白 18 血清水平相关。
Ann Hepatol. 2022 Nov-Dec;27(6):100756. doi: 10.1016/j.aohep.2022.100756. Epub 2022 Sep 10.
7
Identification and validation of immune related core transcription factors in NAFLD.鉴定和验证非酒精性脂肪性肝病中与免疫相关的核心转录因子。
PeerJ. 2022 Jul 21;10:e13735. doi: 10.7717/peerj.13735. eCollection 2022.
8
The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver disease.多酚与微小RNA之间的关系:代谢相关脂肪性肝病的一种新型治疗策略。
Hepatol Forum. 2021 Sep 15;2(3):128-136. doi: 10.14744/hf.2021.2021.0037. eCollection 2021 Sep.
9
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.代谢相关脂肪性肝病(MAFLD):一种超越肝脏的多系统疾病。
J Clin Transl Hepatol. 2022 Apr 28;10(2):329-338. doi: 10.14218/JCTH.2021.00178. Epub 2021 Oct 19.
10
A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis.一种过表达 circRNA_0001805 的纳米药物系统通过 miR-106a-5p/miR-320a 和 ABCA1/CPT1 轴缓解非酒精性脂肪性肝病。
J Nanobiotechnology. 2021 Nov 17;19(1):363. doi: 10.1186/s12951-021-01108-8.